Research Institute Brainclinics was founded in 2001 as an independent research institute, specialised in advancing the understanding of psychiatric disorders through brain imaging (QEEG, ERPs), chronobiology and sleep, Research Domain Criteria (RDoC), which knowledge should aid in a future of personalised medicine in mental health. Brainclinics is further specialised in the development and application of neuromodulation techniques such as neurofeedback in the treatment of ADHD and magnetic brain stimulation (rTMS) in the treatment of depression and OCD.
Under the same name, Psychology Practice Brainclinics was founded in 2006. In this clinic new innovative treatments (neuromodulation techniques) were pioneered such as rTMS (Brain stimulation) in the treatment of depression (since 2006), OCD and Neurofeedback in the treatment of ADHD. In 2015 this clinic was acquired by the neuroCare Group and the protocols and assessments developed here form the basis for all neuroCare Clinics worldwide and more information can be found on the neuroCare website.

ADHD

ADHD stands for Attention Deficit Hyperactivity Disorder. ADHD often distinguishes ADHD with hyperactivity (ADHD) and without hyperactivity (ADD).

Sleep

Sleep plays a fundamental role in our daily functioning, and it can play a role in the development of complaints that are also seen in ADHD.

Depression

Depression is one of the most common mental disorders and is distinguished from “normal” sadness by the nature and duration of symptoms.

Research

Brainclinics was established in 2001 as a research institute specialized in Applied Neuroscience, Neuromodulation, and Personalized Medicine.